Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Anna K. McGill"'
Autor:
Patricia D. Murphy, Rachel T. Klein, Kathleen S. Hruska, E Sutcliffe, Anna K. McGill, KJ Vogel Postula
Publikováno v:
Cancer Research. 79:P5-09
Background: PARP inhibitors (PARPi) are FDA approved for a subset of metastatic human epidermal growth factor receptor 2-negative (H2N) breast cancer patients who harbor a germline pathogenic or likely pathogenic variant (PV) in BRCA1/2, two of the m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed247ad76a0da88f6af0b186d062cc1e
https://doi.org/10.1158/1538-7445.sabcs18-p5-09-08
https://doi.org/10.1158/1538-7445.sabcs18-p5-09-08
Abstract PD7-11: The role of multi-gene hereditary cancer panels in male patients with breast cancer
Autor:
Anna K. McGill, KJ Vogel Postula, Rachel T. Klein, K Theobald, E Sutcliffe, Kathleen S. Hruska, Patricia D. Murphy, Kevin J. Arvai, LM Andolina
Publikováno v:
Cancer Research. 78:PD7-11
Background/Statement of Purpose: The role of cancer susceptibility genes in the male breast cancer population beyond BRCA1 and BRCA2 (BRCA) is not well defined. While breast cancer has been documented in men with pathogenic variants in a number of ot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::511f3767a7fb2598a2d3ea36cfacb676
https://doi.org/10.1158/1538-7445.sabcs17-pd7-11
https://doi.org/10.1158/1538-7445.sabcs17-pd7-11
Autor:
Zhixiong Xu, Natalie J. Carter, Kathleen S. Hruska, Susan Hiraki, Rachel T. Klein, Kevin J. Arvai, Lisa R. Susswein, Rebecca I. Torene, Kristin K. Zorn, Megan L. Marshall, Lauren Yackowski, Anna K. McGill, Patricia D. Murphy, Benjamin D. Solomon
Publikováno v:
Gynecologic oncology. 151(3)
The recognition of genes implicated in ovarian cancer risk beyond BRCA1, BRCA2, and the Lynch syndrome genes has increased the variety of testing options available to providers and patients. We report the frequency of pathogenic variants identified a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b83ff799b0ce1fb5f5adb68407e7b684
https://pubmed.ncbi.nlm.nih.gov/30322717
https://pubmed.ncbi.nlm.nih.gov/30322717
Autor:
Elizabeth A Wiley, Anna K. McGill, Lisa R. Susswein, Megan L. Marshall, Natalie J. Carter, Rachel T. Klein, Ying Wang, Kathleen S. Hruska, Shirley A Yao
Publikováno v:
Journal of Clinical Oncology. 36:668-668
668 Background: Approximately 25% of pheochromocytomas (PCC) have a hereditary basis, and germline variants in the SDHA, SDHB, SDHC, SDHD, SDHAF2, TMEM127, MAX, VHL, FH, RET, MEN1, and NF1 genes have been associated with a predisposition to PCC and p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54eef8b4eb3ef78198a620cc0e8d0387
https://doi.org/10.1200/jco.2018.36.6_suppl.668
https://doi.org/10.1200/jco.2018.36.6_suppl.668
Autor:
Kathleen S. Hruska, Anna K. McGill, Erica M Webb, Rachel T. Klein, Megan L. Marshall, Zhixiong Xu, Maegan E. Roberts, Lisa R. Susswein
Publikováno v:
Journal of Clinical Oncology. 36:596-596
596 Background: Lynch syndrome (LS), also known as hereditary non-polyposis colorectal cancer (HNPCC), is a hereditary colorectal cancer syndrome thought to present with few or no polyps. It has been suggested that the majority of LS patients with co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39222192d0f58e44130bd8746ab1e98d
https://doi.org/10.1200/jco.2018.36.4_suppl.596
https://doi.org/10.1200/jco.2018.36.4_suppl.596
Autor:
Zhixiong Xu, Megan L. Marshall, Maegan E. Roberts, Rachel T. Klein, Anna K. McGill, Kathleen S. Hruska, Lisa R. Susswein
Publikováno v:
Journal of Clinical Oncology. 36:576-576
576 Background: Young age at onset is a hallmark feature of an inherited predisposition to cancer. Recent evidence suggests that the incidence of pathogenic/likely pathogenic variants (PV) in cancer predisposition genes among individuals diagnosed wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bbee296e2ab975424a6561390b613b2d
https://doi.org/10.1200/jco.2018.36.4_suppl.576
https://doi.org/10.1200/jco.2018.36.4_suppl.576
Autor:
Kristen J. Vogel Postula, Megan L. Marshall, Anna K. McGill, Corrine Fillman, Lisa R. Susswein, Zhixiong Xu, Rachel T. Klein, Kathleen S. Hruska, Katherine A Skora, Sheila R. Solomon
Publikováno v:
Journal of Clinical Oncology. 35:244-244
244 Background: Pancreatic ductal adenocarcinoma (PC) is associated with multiple hereditary cancer syndromes. Genes implicated in hereditary PC include ATM, BRCA1, BRCA2, CDKN2A, EPCAM, MLH1, MSH2, MSH6, PALB2 and PMS2. The advent of multi-gene here
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49cf9870cb72cadb7792c4d163f7cc9d
https://doi.org/10.1200/jco.2017.35.4_suppl.244
https://doi.org/10.1200/jco.2017.35.4_suppl.244